blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3060276

EP3060276 - INFUSION SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLE MEDICAMENTS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  21.04.2023
Database last updated on 19.07.2024
FormerGrant of patent is intended
Status updated on  22.12.2022
FormerExamination is in progress
Status updated on  18.05.2018
Most recent event   Tooltip12.07.2024New entry: Reply of patent proprietor to notice(s) of opposition 
Applicant(s)For all designated states
Trustees of Boston University
108 Bay State Road
Boston, MA 02215 / US
[2016/35]
Inventor(s)01 / DAMIANO, Edward R.
22 Putnam Road
Acton, MA 01720 / US
02 / RAMEY, Kirk D.
2701 NE 4th Street
Pompano Beach, FL 33062 / US
03 / EL-KHATIB, Firas H.
59 Brainerd Road
Unit 218
Allston, MA 02134 / US
 [2016/35]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[N/P]
Former [2023/21]Windsor, Louise, et al
Sweetinburgh & Windsor
Churchill Court
3 Manor Royal
Crawley, West Sussex RH10 9LU / GB
Former [2016/35]Windsor, Louise, et al
Sweetinburgh and Windsor Ltd
Unit 76, Basepoint
Metcalf Way
Crawley, West Sussex RH11 7XX / GB
Application number, filing date14799592.224.10.2014
[2016/35]
WO2014US62186
Priority number, dateUS201361895279P24.10.2013         Original published format: US 201361895279 P
US201361895288P24.10.2013         Original published format: US 201361895288 P
US201361895270P24.10.2013         Original published format: US 201361895270 P
US201461932835P29.01.2014         Original published format: US 201461932835 P
US201462011306P12.06.2014         Original published format: US 201462011306 P
[2016/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015061690
Date:30.04.2015
Language:EN
[2015/17]
Type: A1 Application with search report 
No.:EP3060276
Date:31.08.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 30.04.2015 takes the place of the publication of the European patent application.
[2016/35]
Type: B1 Patent specification 
No.:EP3060276
Date:24.05.2023
Language:EN
[2023/21]
Search report(s)International search report - published on:EP30.04.2015
ClassificationIPC:A61M5/168, A61M5/14, A61M39/10
[2022/52]
CPC:
A61M5/1413 (EP,IL,US); A61M5/1452 (IL,US); A61M5/14248 (IL,US);
A61M5/162 (IL,US); A61M5/16831 (EP,IL,US); A61M5/1723 (IL,US);
A61M2005/14208 (IL,US); A61M2039/1094 (EP,IL,US); A61M2202/07 (IL,US);
A61M2205/14 (IL,US); A61M2205/18 (IL,US); A61M2205/276 (IL,US);
A61M2205/52 (IL,US); A61M2205/6036 (EP,IL,US); A61M2205/6045 (EP,IL,US) (-)
Former IPC [2016/35]A61M5/19, A61M5/142, A61M5/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/35]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:INFUSION SYSTEM ZUR VERMEIDUNG FALSCH CHANNELING MEHRERER MEDIKAMENTE[2022/52]
English:INFUSION SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLE MEDICAMENTS[2016/35]
French:SYSTÈME DE PERFUSION POUR PRÉVENIR FAUX CHANNELING DE MEDICAMENTS MULTIPLES[2022/52]
Former [2016/35]INFUSIONSSYSTEM ZUR VERHINDERUNG DER FEHLLEITUNG MEHRERER MEDIKAMENTE
Former [2016/35]SYSTÈME DE PERFUSION PERMETTANT DE PRÉVENIR LE MAUVAIS ROUTAGE DE MULTIPLES MÉDICAMENTS
Entry into regional phase24.05.2016National basic fee paid 
24.05.2016Designation fee(s) paid 
24.05.2016Examination fee paid 
Examination procedure24.05.2016Amendment by applicant (claims and/or description)
24.05.2016Examination requested  [2016/35]
22.05.2018Despatch of a communication from the examining division (Time limit: M06)
14.01.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
12.03.2019Reply to a communication from the examining division
19.11.2019Despatch of a communication from the examining division (Time limit: M06)
05.05.2020Reply to a communication from the examining division
23.12.2022Communication of intention to grant the patent
08.03.2023Receipt of the translation of the claim(s)
10.04.2023Fee for grant paid
10.04.2023Fee for publishing/printing paid
Opposition(s)Opponent(s)01  20.02.2024  23.02.2024  ADMISSIBLE
Inreda Diabetic B.V.
Klavermaten 65-5
7472 DD Goor / NL
Opponent's representative
Custos IPC Coöperatie U.A.
Molenstraat 20
7551 DC Hengelo / NL
 [2024/14]
Former [2024/13]
Opponent(s)01  20.02.2024   
Inreda Diabetic B.V.
Klavermaten 65-5
7472 DD Goor / NL
Opponent's representative
Custos IPC Coöperatie U.A.
Molenstraat 20
7551 DC Hengelo / NL
11.03.2024Invitation to proprietor to file observations on the notice of opposition
11.07.2024Reply of patent proprietor to notice(s) of opposition
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
12.03.2019Request for further processing filed
12.03.2019Full payment received (date of receipt of payment)
Request granted
22.03.2019Decision despatched
Fees paidRenewal fee
19.09.2016Renewal fee patent year 03
27.10.2017Renewal fee patent year 04
29.10.2018Renewal fee patent year 05
28.10.2019Renewal fee patent year 06
27.10.2020Renewal fee patent year 07
27.10.2021Renewal fee patent year 08
27.10.2022Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.05.2023
CZ24.05.2023
DK24.05.2023
EE24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
MC24.05.2023
NL24.05.2023
PL24.05.2023
RO24.05.2023
RS24.05.2023
SE24.05.2023
SI24.05.2023
SK24.05.2023
SM24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
LU24.10.2023
[2024/30]
Former [2024/28]AT24.05.2023
CZ24.05.2023
DK24.05.2023
EE24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
MC24.05.2023
NL24.05.2023
PL24.05.2023
RO24.05.2023
RS24.05.2023
SE24.05.2023
SI24.05.2023
SK24.05.2023
SM24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2024/24]AT24.05.2023
CZ24.05.2023
DK24.05.2023
EE24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
NL24.05.2023
PL24.05.2023
RO24.05.2023
RS24.05.2023
SE24.05.2023
SI24.05.2023
SK24.05.2023
SM24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2024/10]AT24.05.2023
CZ24.05.2023
DK24.05.2023
EE24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
NL24.05.2023
PL24.05.2023
RO24.05.2023
RS24.05.2023
SE24.05.2023
SK24.05.2023
SM24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2024/08]AT24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
NL24.05.2023
PL24.05.2023
RS24.05.2023
SE24.05.2023
SK24.05.2023
SM24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2024/01]AT24.05.2023
HR24.05.2023
LT24.05.2023
LV24.05.2023
NL24.05.2023
PL24.05.2023
RS24.05.2023
SE24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2023/51]AT24.05.2023
HR24.05.2023
NL24.05.2023
PL24.05.2023
RS24.05.2023
SE24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2023/50]AT24.05.2023
NL24.05.2023
PL24.05.2023
SE24.05.2023
NO24.08.2023
GR25.08.2023
IS24.09.2023
PT25.09.2023
Former [2023/48]AT24.05.2023
NL24.05.2023
SE24.05.2023
NO24.08.2023
PT25.09.2023
Former [2023/46]PT25.09.2023
Cited inInternational search[XI]WO2004045704  (BIOMETRIX LTD [IL], et al) [X] 1 * abstract * * figures 1a-1d * [I] 2-24;
 [XI]WO2012110474  (SANOFI AVENTIS DEUTSCHLAND [DE], et al) [X] 1-6,8-10,13,16,24 * abstract * * claim 1 * * page 30, paragraph 3 * * figures 1,19 * [I] 7,11,12,14,15,17-23;
 [A]US2013237947  (AMIROUCHE FARID [US], et al) [A] 1-24 * abstract ** figure - *
by applicantUS7806854
OppositionWO2004045704
 WO2007047279
 WO2012110474
 WO2013173157
 CN104027867
 WO2015061690
    - Helga Blauw, "Kunstpancreas voor geautomatiseerde glucoseregulatie", Ned Tijdschr Geneeskd, (20131216), vol. 157, pages 1 - 3, XP093165117
    - T. Van Dam, "Goors bedrijf Inreda Diabetic finalist Herman Wijffels Innovatieprijs 2013", Inreda Diabetic B.V. - Press Release, (20131017), Inreda Diabetic B.V. - Press Release, XP093165108
    - Anonymous, "adapted", Collins Dictionary, (20230101), Collins Dictionary, URL: https://www.collinsdictionary.com/dictionary/english/adapted, XP093165119
    - Anonymous, "configure", Collins Dictionary, (20230101), Collins Dictionary, URL: https://www.collinsdictionary.com/dictionary/english/configure, XP093165122
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.